Mariya Mushtaq, Dr Bilal A Bhat
Every November, as National Cancer Awareness Day approaches, ribbons appear on lapels, hospitals host free screening camps, and public health advisories fill newspapers and social media feeds. Yet cancer does not adhere to a calendar. While designated awareness days serve as vital reminders, the real battle against the disease is won or lost in the quiet, ordinary decisions made across the remaining 364 days of the year. Over the past few decades, oncology has undergone one of the most profound transformations in modern medicine. Still, the gap between what medical science can achieve and how early patients reach a clinic remains wide. Bridging that divide requires replacing seasonal symbolism with year-round vigilance, informed prevention, and a willingness to confront long-standing social taboos.
Cancer |Then And Now: For generations, a cancer diagnosis carried an air of inevitability. In earlier decades, public understanding of the disease was limited, diagnostic infrastructure was sparse, and specialized oncology centers were concentrated in a handful of metropolitan cities. For most families, particularly in smaller towns and rural regions, advanced imaging, specialized histopathology, and multidisciplinary cancer care were out of reach. Because subtle early symptoms were frequently dismissed or treated empirically without definitive testing, the majority of malignancies were identified only at advanced stages. By the time a patient reached a tertiary hospital, treatment options were often restricted to aggressive surgery or palliative care, reinforcing the widespread belief that cancer was uniformly untreatable. Today, the clinical landscape looks remarkably different. Advances in high-resolution diagnostic imaging such as digital mammography, low-dose computed tomography (CT), magnetic resonance imaging (MRI), and positron emission tomography (PET-CT) allow clinicians to detect abnormalities far earlier than was once possible. Alongside imaging, modern pathology, immunohistochemistry, and molecular profiling enable doctors to classify tumours with precision, tailoring therapies to the specific biological behaviour of a patient’s disease. Treatment itself has evolved beyond conventional surgery, chemotherapy, and radiation. Targeted therapies, immunotherapy, minimally invasive surgical techniques, and precision radiotherapy have substantially improved survival rates and quality of life for many cancers provided the disease is caught in time.
The Growing Challenge In Jammu And Kashmir: Nowhere is the urgency of timely detection more evident than in Jammu and Kashmir, where epidemiological data point to a steady rise in cancer burden. According to estimates from the Indian Council of Medical Research–National Cancer Registry Programme (ICMR–NCRP) tabled in Parliament, Jammu and Kashmir recorded 68,804 estimated cancer cases between 2021 and 2025, rising year-on-year from 13,060 cases in 2021 to 14,493 in 2025. Separate health department figures presented in the Jammu and Kashmir Legislative Assembly similarly documented over 32,400 registered cancer cases across the Union Territory in a three-year span (2023–2025). Data from hospital- and population-based registries, including the State Cancer Institute at the Sher-i-Kashmir Institute of Medical Sciences (SKIMS) in Srinagar and tertiary centers in Jammu, highlight clear patterns in the region’s cancer profile:
• Breast Cancer: Breast malignancy has emerged as the leading cancer among women in the region, accounting for roughly 18.6% nearly one in five of all female cancers recorded in the Kashmir registry. Clinical studies from both Jammu and Kashmir divisions indicate that a significant proportion of women still present at Stage II or Stage III, and a notable share of patients are diagnosed in their late 30s and 40s.
• Lung And Upper Aero Digestive Cancers: Lung cancer consistently ranks among the most frequently diagnosed malignancies in J&K, particularly among men, closely linked to high rates of tobacco smoking including cigarettes, hookah, and smokeless tobacco as well as indoor air pollution. Oral and oesophageal cancers also remain prominent.
• Gastrointestinal Cancers: Stomach and colorectal cancers continue to represent a substantial share of the regional caseload, prompting targeted research and screening initiatives by national medical bodies.
• Cervical And Other Cancers: Cervical, prostate, and pancreatic cancers also feature among the commonly reported malignancies across the Union Territory.
While specialized facilities such as the State Cancer Institutes in Srinagar and Jammu have expanded access to advanced diagnostics including PET-CT scans and radiotherapy, geographic barriers, winter weather disruptions, and uneven peripheral screening infrastructure mean that rural and remote communities still face delays in diagnosis. Strengthening district-level screening and community health outreach remains essential so patients do not have to wait until symptoms become severe before seeking care.
Why Early Detection Changes Everything: Across almost every form of oncology, the single strongest predictor of treatment success is the stage at which the disease is diagnosed. When a tumour is localized to its site of origin, treatments are generally less intensive, less costly, and far more likely to achieve long-term remission or cure. Once cancer spreads to regional lymph nodes or distant organs, management becomes significantly more complex. It is important to recognize that there is no single universal test for all cancers; screening strategies vary depending on the organ involved and an individual’s risk profile:
• Breast Cancer can be detected early through clinical breast examination and mammography.
• Cervical Cancer is preventable and detectable in precancerous stages through Pap smears, visual inspection with acetic acid (VIA), and Human Papillomavirus (HPV) DNA testing.
• Oral Cancers can often be identified early through routine visual examination of the mouth, especially in tobacco users.
• Colorectal And Lung Cancers have established screening protocols such as stool-based tests, colonoscopy, or low-dose CT scans for specific age groups and high-risk individuals.
Equally vital is recognizing early warning signs: an unexplained lump, persistent cough or hoarseness, non-healing mouth ulcers, unusual bleeding or discharge, sudden unexplained weight loss, persistent indigestion or difficulty swallowing, or a noticeable change in bowel or bladder habits. Most of these symptoms turn out to have non-cancerous causes; yet evaluating them promptly ensures that if cancer is present, valuable time is not lost.
“Beating cancer requires individual vigilance, family support, empathetic healthcare, and equitable public health policy—making cancer awareness an ongoing commitment, not an annual event, to save lives through early action.”
